View More Recent Stories
-
Wall Street Hubbub 7/14: iPhone 4 Recall, Penthouse-for-Playboy, BP's New Cap Is No Savior, KKR IPO, Treasury Weighs Citi (C) Options
-
Citi Reiterates a 'Buy' on Allergan (AGN); Focus is on Sequential Aesthetics Growth
-
After-Hours Movers 3/9: FACT, ITMN, EXLS, ALOG, AGN Higher; EQT, SAM, AVAV, ACAD, FLOW, JMBA, MITI Lower
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
-
Citi Upgrades Allergan (AGN) to Buy
-
Sanofi-Aventis (SNY) On the Prowl For A Mega-Deal In the U.S.?
-
Active equity option families in first 30 minutes of trading according to Track Data: BAC GE GS C AGN
-
Notable Analyst Rating Changes 3/12: JCI, SNP, HXL Upgraded; DKS, LDK, CCI, PLD Downgraded
-
Citi Maintains 'Hold' on Allergan (AGN), But Increases Price Target Saying Ophthalmology Offsetting Aesthetics Weakness
-
Morning Movers 12/04: Merck (MRK) Lower On Guidance, Amazon.com (AMZN) Higher On Upgrade
-
Unusual 11 Mid-Day Movers 9/11: BBND, CPSL, CAL, JOYG Higher; LEH, KNXA, IDCC, TKTM Lower
-
Citi Adds Kohl's (KSS) and Nike (NKE) to Recommended List; Removes NWS, MRO and AGN
-
Citi Downgrades Allergan (AGN) to Hold
-
Citi Assumes Coverage on Ophthalmology Names - ACL, AGN, COO and EYE

